HomeEW • NYSE
Edwards Lifesciences Corp
Follow
Key events shows relevant news articles on days with large price movements
Key events shows relevant news articles on days with large price movements
Key events shows relevant news articles on days with large price movements
Boston Scientific Corp
$62.56
BSX1.13%
Stryker Corp
$340.01
SYK2.39%
Medtronic PLC
$88.65
MDT2.58%
Abbott Laboratories
$103.56
ABT1.70%
Intuitive Surgical Inc
$462.28
ISRG2.06%
Becton Dickinson and Co
$157.09
BDX1.37%
Resmed Inc
$230.70
RMD2.06%
Zimmer Biomet Holdings, Inc
$93.01
ZBH1.76%
DexCom Inc
$65.80
DXCM4.26%
Johnson & Johnson
$241.30
JNJ1.21%
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info Fiscal Q4 2025 ended 12/31/25. | Y/Y change |
|---|---|---|
Revenue The total amount of income generated by the sale of goods or services related to the company's primary operations | 1.57B | 13.26% |
Operating expense Represents the total incurred expenses through normal operations | 854.60M | 15.53% |
Net income Company’s earnings for a period net of operating costs, taxes, and interest | 91.20M | -76.35% |
Net profit margin Measures how much net income or profit is generated as a percentage of revenue. | 5.81 | -79.12% |
Earnings per share Represents the company's profit divided by the outstanding shares of its common stock. | 0.58 | -1.69% |
EBITDA Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances | 414.70M | 4.56% |
Effective tax rate The percent of their income that a corporation pays in taxes | 28.98% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info Fiscal Q4 2025 ended 12/31/25. | Y/Y change |
|---|---|---|
Cash and short-term investments Investments that are relatively liquid and have maturities between 3 months and one year | 4.23B | 6.30% |
Total assets The total amount of assets owned by a company | 13.70B | 4.92% |
Total liabilities Sum of the combined debts a company owes | 3.36B | 12.27% |
Total equity The value of subtracting the total liabilities from the total assets of a company | 10.34B | — |
Shares outstanding Total number of common shares outstanding as of the latest date disclosed in a financial filing | 580.80M | — |
Price to book A ratio used to determine if a company’s market value is in line with the value of its assets less liabilities and preferred stock | 4.54 | — |
Return on assets A financial ratio that shows a company’s profitability compared to its assets | 6.90% | — |
Return on capital Company’s return above the average cost it pays for its debt and equity capital | 8.47% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info Fiscal Q4 2025 ended 12/31/25. | Y/Y change |
|---|---|---|
Net income Company’s earnings for a period net of operating costs, taxes, and interest | 91.20M | -76.35% |
Cash from operations Net cash used or generated for core business activities | 450.90M | 453.65% |
Cash from investing Net cash used or generated in investing activities such as purchasing assets | -198.30M | 65.61% |
Cash from financing Net cash used or generated in financing activities such as dividend payments and loans | -11.40M | -139.86% |
Net change in cash The amount by which a company's cash balance increases or decreases in an accounting period | 244.70M | 139.18% |
Free cash flow Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments | 436.75M | 298.08% |
Stock
Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned
US listed securityListed on NYSE
US headquarteredHeadquartered in Irvine, California, United States
Previous close
The last closing price
$80.84
Day range
The range between the high and low prices over the past day
$81.36 - $82.77
Year range
The range between the high and low prices over the past 52 weeks
$65.94 - $87.89
Market cap
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.
47.11B USD
Avg Volume
The average number of shares traded each day over the past 30 days
4.57M
P/E ratio
The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks
45.15
Dividend yield
The ratio of annual dividend to current share price that estimates the dividend return of a stock
-
Primary exchange
Listed exchange for this security
NYSE
About
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility completed in 2021 in Limerick, Ireland. Wikipedia
Founded
1958
Headquarters
Website
Employees
16,000
